After studies showed certain vaccines had a protective effect against Alzheimer's, researchers wanted to see if treating the virus might slow disease progression.However in a group of people with early Alzheimer's disease this had no effect on cognitive decline. Also, a new study urges us to rethink the side effects of statins. And GLP-1s under the spotlight for nutritional deficiencies and muscle loss. ReferencesValacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical TrialAssessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trialsNutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related